Loading
Latest filing published 21 May 2021 for RIGEL PHARMACEUTICALS INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Only one filing by Bradford S. Goodwin is known so far (21 May 2021): a share grant, in Rigel Pharmaceuticals Inc. That is too little to draw conclusions. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration